Concepedia

Wenyue Cao

WC

Statistics

Publications

13

Citations

785

H-Index

12

Active since

2018

Affiliations

Tongji Hospital(Current)

Huazhong University of Science and Technology

Wuhan University of Science and Technology

Wuhan Institute of Bioengineering

Texas A&M University

Wenyue Cao is an author at Tongji Hospital specializing in medicine, immunology, and chimeric antigen receptor t-cell therapy.

ORCID

Publications per year

2018–2022

13

Publications

13

Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies

Na Wang, Xuelian Hu, Wenyue Cao et al. · Blood · 2019 · 264 citations · Full text

, , +12

Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6

Wenhao Niu, Feng Wu, Wenyue Cao et al. · Bioscience Reports · 2020 · 109 citations · Full text

, , +17

A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia

Chunrui Li, Wenyue Cao, Yimei Que et al. · Clinical and Translational Medicine · 2021 · 69 citations · Full text

, , +16

Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel Cell-Based Assay

Wenyue Cao, Chia-Chuan Dean Cho, Zhi Geng et al. · ACS Central Science · 2022 · 56 citations · Full text

, , +15

Entecavir prophylaxis for hepatitis B virus reactivation in patients with CAR T-cell therapy

Wenyue Cao, Jia Wei, Na Wang et al. · Blood · 2020 · 49 citations · Full text

, , +14

1–5 of 13